Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Other Non Operating Income (2021 - 2026)

HeartSciences (HSCS) has disclosed Other Non Operating Income for 5 consecutive years, with $2168.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 89.0% year-over-year to $2168.0, compared with a TTM value of $26559.0 through Oct 2025, down 78.01%, and an annual FY2025 reading of $87795.0, up 60.67% over the prior year.
  • Other Non Operating Income was $2168.0 for Q4 2025 at HeartSciences, down from $2813.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $250200.0 in Q3 2021 and bottomed at -$249349.0 in Q1 2022.
  • Average Other Non Operating Income over 5 years is $24967.1, with a median of $2490.5 recorded in 2025.
  • The sharpest move saw Other Non Operating Income tumbled 99.9% in 2023, then skyrocketed 657000.0% in 2024.
  • Year by year, Other Non Operating Income stood at $250200.0 in 2021, then plummeted by 99.52% to $1199.0 in 2022, then plummeted by 99.75% to $3.0 in 2023, then surged by 657000.0% to $19713.0 in 2024, then tumbled by 89.0% to $2168.0 in 2025.
  • Business Quant data shows Other Non Operating Income for HSCS at $2168.0 in Q4 2025, $2813.0 in Q3 2025, and $6921.0 in Q2 2025.